Shulman DeMeo Asset Management LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Shulman DeMeo Asset Management LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$21,682
-23.9%
15,4870.0%0.01%
-22.2%
Q2 2023$28,496
-24.3%
15,4870.0%0.01%
-25.0%
Q1 2023$37,633
+69.9%
15,4870.0%0.01%
+71.4%
Q4 2022$22,146
-36.7%
15,4870.0%0.01%
-41.7%
Q3 2022$35,00015,4870.01%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders